Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations

Campbell "Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021" Euro Surveill. (2021) 10.2807/1560-7917.es.2021.26.24.2100509

[5]

World Health Organization. Weekly epidemiological update on COVID-19: 11 May 2021. . Available online: https://www.who.int/publications/m/item/weekly-epidemiological -update-on-covid-19—11-may-2021.

[6]

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines

Yusha Araf, Fariya Akter, Yan‐dong Tang et al.

Journal of Medical Virology 2022 10.1002/jmv.27588

[7]

Liu "Reduced neutralization of SARS-CoV-2 B1.617 by vaccine and convalescent serum" Cell (2021) 10.1016/j.cell.2021.06.020

[8]

Planas "Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization" Nature (2021) 10.1038/s41586-021-03777-9

[9]

Chen "Clinical Characteristics of Covid-19 in China" N. Engl. J. Med. (2020) 10.1056/nejmc2009226

[10]

Chen "Clinical and immunological features of severe and moderate coronavirus disease 2019" J. Clin. Invest. (2020) 10.1172/jci137244

[11]

Lee "Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19" Sci. Immunol. (2020) 10.1126/sciimmunol.abd1554

[12]

McElvaney "Characterization of the Inflammatory Response to Severe COVID-19 Illness" Am. J. Respir. Crit. Care Med. (2020) 10.1164/rccm.202005-1583oc

[13]

Maucourant "Natural killer cell immunotypes related to COVID-19 disease severity" Sci. Immunol. (2020) 10.1126/sciimmunol.abd6832

[14]

Bui "Single-cell RNA-sequencing reveals dysregulation of molecular programs associated with SARS-CoV-2 severity and outcomes in patients with chronic lung disease" bioRxiv (2020)

[15]

Emery "The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess Cruise Ship" elife (2020) 10.7554/elife.58699

[16]

Bohn "Pathophysiology of COVID-19: mechanisms underlying disease severity and progression" Physiology (Bethesda). (2020)

[17]

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Lauren B. Rodda, Jason Netland, Laila Shehata et al.

Cell 2021 10.1016/j.cell.2020.11.029

[18]

Lei "Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections" Allergy (2021) 10.1111/all.14622

[19]

Achiron "SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects" Clin. Microbiol. Infect. (2021) 10.1016/j.cmi.2021.05.008

[20]

Gurevich "SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients" Int. J. Infect. Dis. (2022) 10.1016/j.ijid.2021.12.309

[21]

Rabets "The potential of developing pan-coronaviral antibodies to spike peptides in convalescent COVID-19 patients" Arch. Immunol. Ther. Exp. (Warsz.) (2021) 10.1007/s00005-021-00607-8

[22]

Wooding "Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks" Clin. Microbiol. Infect. (2020) 10.1016/j.cmi.2020.08.005

[23]

Hueso "Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19" Blood (2020) 10.1182/blood.2020008423

[24]

Schultheiss "Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease" Immunity (2020) 10.1016/j.immuni.2020.06.024

[25]

(2021)

[26]

World Health Organization (2020): Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. https://www.who.int/health-topics/coronavirus/laboratory-diagnostics-for-novel-coronavirus. [Accessed March 19, 2020].

[27]

World Health Organization (2020): “COVID-19: surveillance, case investigation and epidemiological protocols; https://www.who.int/internal-publications-detail/considerations-in-the-investigation-of-cases-and-clusters-of-covid-19 [Accessed October 22, 2020].

[28]

Structural Biology in the Clouds: The WeNMR-EOSC Ecosystem

Rodrigo V. Honorato, Panagiotis I. Koukos, Brian Jiménez-García et al.

Frontiers in Molecular Biosciences 2021 10.3389/fmolb.2021.729513

[29]

The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes

G.C.P. van Zundert, J.P.G.L.M. Rodrigues, M. Trellet et al.

Journal of Molecular Biology 2016 10.1016/j.jmb.2015.09.014

[30]

(2008)

[31]

Wang "Identification of distinct immune cell subsets associated with asymptomatic infection, disease severity, and viral persistence in COVID-19 patients" Front Immunol. (2022)

[32]

Raybould "CoV-AbDab: the coronavirus antibody database" Bioinformatics (2021) 10.1093/bioinformatics/btaa739

[33]

Jeon "VDJ gene usage of B Cell Receptors in peripheral blood of ABO-incompatible kidney transplantation patients" Transplant. Proc. (2018) 10.1016/j.transproceed.2018.01.047

[34]

Cagigi "Vaccine generation of protective ebola antibodies and identification of conserved B-cell signatures" J. Infect. Dis. (2018) 10.1093/infdis/jiy333

[35]

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

Wen Wen, Wenru Su, Hao Tang et al.

Cell Discovery 2020 10.1038/s41421-020-0168-9

[36]

Nielsen "Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2" Cell Host Microbe (2020) 10.1016/j.chom.2020.09.002

[37]

Belhouachi "Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire" Blood Adv. (2020) 10.1182/bloodadvances.2019000980

[38]

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto, Young-Jun Park, Martina Beltramello et al.

Nature 2020 10.1038/s41586-020-2349-y

[39]

A molecular single-cell lung atlas of lethal COVID-19

Johannes C. Melms, Jana Biermann, Huachao Huang et al.

Nature 2021 10.1038/s41586-021-03569-1

[40]

Gubbins "Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus" Mol. Immunol. (2005) 10.1016/j.molimm.2004.06.032

[41]

CN111909260A. Available online: https://patents.google.com/patent/CN111909260A/en.

[42]

WO2005060520. Available online: https://patentimages.storage.googleapis.com/5a/11/f4/7f766a82568126/WO2005060520A2.pdf.

[43]

Han "A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBD" bioRxiv (2020)

[44]

Robbiani "Convergent antibody responses to SARS-CoV-2 in convalescent individuals" Nature (2020) 10.1038/s41586-020-2456-9

[45]

Noy-Porat "Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice" iScience (2021) 10.1016/j.isci.2021.102479

Metrics

12

Citations

45

References

Details

Published: Sep 01, 2022
Vol/Issue: 249
Pages: 23-32
License: View

Authors

Artificial Intelligence and Software College, Liaoning Petrochemical University, Fushun, P. R. China

Funding

Xi’an Jiaotong University

Cite This Article

Junpeng Ma, Han Bai, Tian Gong, et al. (2022). Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations. Immunology Letters, 249, 23-32. https://doi.org/10.1016/j.imlet.2022.08.006

Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations

You May Also Like